Peter J. Graham's most recent trade in Adc Therapeutics SA was a trade of 294,800 Common Shares done at an average price of $4.0 . Disclosure was reported to the exchange on Feb. 13, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adc Therapeutics SA | Peter J. Graham | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 3.99 per share. | 13 Feb 2026 | 294,800 | 653,834 | - | 4.0 | 1,176,252 | Common Shares |
| Adc Therapeutics SA | Peter J. Graham | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.99 per share. | 13 Feb 2026 | 33,294 | 620,540 | - | 4.0 | 132,843 | Common Shares |
| Adc Therapeutics SA | Peter J. Graham | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.29 per share. | 06 Dec 2025 | 49,508 | 359,034 | - | 3.3 | 162,881 | Common Shares |
| Adc Therapeutics SA | Peter J. Graham | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 1.61 per share. | 13 Feb 2025 | 220,000 | 408,542 | - | 1.6 | 354,200 | Common Shares |
| Adc Therapeutics SA | Peter J. Graham | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 06 Dec 2024 | 41,458 | 188,542 | - | 3.1 | 129,764 | Common Shares |